科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/05/19 | 4,470 | 4,535 | 4,460 | 4,525 | +10 | +0.2% | 120,800 |
| 2021/05/18 | 4,480 | 4,515 | 4,455 | 4,515 | +10 | +0.2% | 135,900 |
| 2021/05/17 | 4,500 | 4,525 | 4,495 | 4,505 | -5 | -0.1% | 101,100 |
| 2021/05/14 | 4,490 | 4,545 | 4,475 | 4,510 | +55 | +1.2% | 83,900 |
| 2021/05/13 | 4,400 | 4,490 | 4,385 | 4,455 | +45 | +1% | 166,000 |
| 2021/05/12 | 4,510 | 4,555 | 4,400 | 4,410 | -140 | -3.1% | 212,200 |
| 2021/05/11 | 4,575 | 4,590 | 4,515 | 4,550 | -40 | -0.9% | 207,200 |
| 2021/05/10 | 4,540 | 4,610 | 4,505 | 4,590 | +45 | +1% | 141,600 |
| 2021/05/07 | 4,580 | 4,605 | 4,495 | 4,545 | -15 | -0.3% | 302,400 |
| 2021/05/06 | 4,600 | 4,605 | 4,520 | 4,560 | +60 | +1.3% | 190,800 |
| 2021/04/30 | 4,460 | 4,550 | 4,445 | 4,500 | +25 | +0.6% | 244,300 |
| 2021/04/28 | 4,465 | 4,475 | 4,425 | 4,475 | +5 | +0.1% | 127,600 |
| 2021/04/27 | 4,460 | 4,490 | 4,450 | 4,470 | +20 | +0.4% | 146,000 |
| 2021/04/26 | 4,495 | 4,495 | 4,420 | 4,450 | -15 | -0.3% | 162,300 |
| 2021/04/23 | 4,450 | 4,470 | 4,415 | 4,465 | +5 | +0.1% | 79,800 |
| 2021/04/22 | 4,450 | 4,465 | 4,435 | 4,460 | +70 | +1.6% | 131,700 |
| 2021/04/21 | 4,395 | 4,400 | 4,360 | 4,390 | -15 | -0.3% | 154,700 |
| 2021/04/20 | 4,400 | 4,420 | 4,390 | 4,405 | +10 | +0.2% | 130,900 |
| 2021/04/19 | 4,400 | 4,440 | 4,395 | 4,395 | +5 | +0.1% | 103,200 |
| 2021/04/16 | 4,360 | 4,390 | 4,340 | 4,390 | +50 | +1.2% | 108,800 |
| 2021/04/15 | 4,350 | 4,365 | 4,315 | 4,340 | +30 | +0.7% | 99,000 |
| 2021/04/14 | 4,320 | 4,325 | 4,280 | 4,310 | -30 | -0.7% | 114,700 |
| 2021/04/13 | 4,345 | 4,365 | 4,325 | 4,340 | +15 | +0.3% | 90,700 |
| 2021/04/12 | 4,325 | 4,330 | 4,290 | 4,325 | +25 | +0.6% | 129,200 |
| 2021/04/09 | 4,265 | 4,330 | 4,260 | 4,300 | +25 | +0.6% | 116,300 |
| 2021/04/08 | 4,310 | 4,340 | 4,260 | 4,275 | -85 | -1.9% | 188,900 |
| 2021/04/07 | 4,245 | 4,360 | 4,245 | 4,360 | +115 | +2.7% | 215,000 |
| 2021/04/06 | 4,295 | 4,315 | 4,240 | 4,245 | -50 | -1.2% | 117,200 |
| 2021/04/05 | 4,310 | 4,340 | 4,285 | 4,295 | -10 | -0.2% | 117,700 |
| 2021/04/02 | 4,355 | 4,370 | 4,305 | 4,305 | -40 | -0.9% | 83,000 |
| 2021/04/01 | 4,390 | 4,390 | 4,335 | 4,345 | +10 | +0.2% | 100,300 |
| 2021/03/31 | 4,420 | 4,430 | 4,330 | 4,335 | -110 | -2.5% | 190,000 |
| 2021/03/30 | 4,515 | 4,515 | 4,435 | 4,445 | -140 | -3.1% | 140,600 |
| 2021/03/29 | 4,585 | 4,620 | 4,545 | 4,585 | +5 | +0.1% | 188,200 |
| 2021/03/26 | 4,540 | 4,590 | 4,520 | 4,580 | +110 | +2.5% | 145,900 |
| 2021/03/25 | 4,480 | 4,510 | 4,460 | 4,470 | -15 | -0.3% | 128,700 |
| 2021/03/24 | 4,545 | 4,545 | 4,465 | 4,485 | -80 | -1.8% | 160,400 |
| 2021/03/23 | 4,655 | 4,670 | 4,565 | 4,565 | -50 | -1.1% | 162,900 |
| 2021/03/22 | 4,585 | 4,630 | 4,575 | 4,615 | +30 | +0.7% | 167,600 |
| 2021/03/19 | 4,555 | 4,610 | 4,540 | 4,585 | ±0 | ±0% | 230,000 |
| 2021/03/18 | 4,590 | 4,625 | 4,560 | 4,585 | +30 | +0.7% | 192,800 |
| 2021/03/17 | 4,475 | 4,555 | 4,450 | 4,555 | +120 | +2.7% | 143,900 |
| 2021/03/16 | 4,480 | 4,480 | 4,410 | 4,435 | -5 | -0.1% | 141,300 |
| 2021/03/15 | 4,305 | 4,440 | 4,305 | 4,440 | +145 | +3.4% | 213,600 |
| 2021/03/12 | 4,375 | 4,375 | 4,285 | 4,295 | -100 | -2.3% | 257,300 |
| 2021/03/11 | 4,470 | 4,485 | 4,375 | 4,395 | -60 | -1.3% | 186,700 |
| 2021/03/10 | 4,520 | 4,575 | 4,425 | 4,455 | +40 | +0.9% | 299,100 |
| 2021/03/09 | 4,300 | 4,420 | 4,290 | 4,415 | +160 | +3.8% | 224,000 |
| 2021/03/08 | 4,255 | 4,290 | 4,240 | 4,255 | +10 | +0.2% | 136,200 |
| 2021/03/05 | 4,250 | 4,275 | 4,220 | 4,245 | -10 | -0.2% | 250,300 |
1001～
1050
件表示中 / 3723件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 383,900円 | -6.4% | -71.8% | 4.95% | 42.88倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 371,500円 | +21.7% | +999.9% | 0.00% | 15.57倍 | 5.15倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 294,500円 | +7.9% | -3.3% | 2.72% | 8.19倍 | 0.84倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 201,700円 | +3.1% | -6.5% | 2.38% | 9.36倍 | 0.99倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
